title: Cabergoline: an advance in dopaminergic therapy.
authors.affiliation: Department of Endocrinology, Aberdeen Royal Infirmary, UK.
authors.forename: J S
authors.initials: JS
authors.lastname: Bevan
authors.forename: J R
authors.initials: JR
authors.lastname: Davis
mesh_terms: D000077465:Cabergoline; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004873:Ergolines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy* / Q000378:metabolism; D010349:Patient Compliance; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism*
chemical_list: D015259:Dopamine Agents; D004873:Ergolines; D011388:Prolactin; D000077465:Cabergoline